⌘K

Home/Filings/4/0000899243-22-013098

4//SEC Filing

Adimab, LLC 4

Accession 0000899243-22-013098

CIK 0001832038other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:08 PM ET

Size

6.8 KB

Accession

0000899243-22-013098

Insider Transaction Report

Form 4

Period: 2022-03-03

Adagio Therapeutics, Inc.ADGI

10% Owner

Transactions

Other
Common Stock
2022-03-03−1,158,089→ 26,687,906 total

Footnotes (1)

[F1]In connection with the resignation of Dr. Tillman Gerngross from the Issuer's Board of directors, the Issuer repurchased 1,158,089 shares of restricted common stock from the Reporting Person for aggregate consideration of $2,316.18.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Adagio Therapeutics, Inc.

CIK 0001832038

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001545672

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 4:08 PM ET
Size: 6.8 KB

View on SEC.gov